An FDA expert panel chairman defies his own panel for endorsing an opioid painkiller
on Fri, 2018-10-19 09:46 Alyssa
In an unusual move, the chair of a Food and Drug Administration panel is defying a recommendation that his own panel made last week to endorse a powerful opioid painkiller, because he believes the drug represents a “danger” to public health. And to make sure his views are known, Dr. Raeford Brown, the panel chair, conveyed his concerns in a letter on Thursday to FDA officials.
Links:
[1] https://www.statnews.com/pharmalot/2018/10/18/fda-panel-opioid-dsuvia/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=66821726&_hsenc=p2ANqtz-9-74QxZyWX9uJPcduXGAhnPxkA7sGqJXP3GcyuO95RvR3IxHL-NDzsPQIQ31WfpAA_tJSnZcnMK8j5uYallAJr1Bh3Lw&_hsmi=66821726